Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
contraception
Pharma
Contraline gins up $92.5M in male birth control development push
Contraline is developing what could be a first-in-class male birth control that has garnered enthusiasm from a host of big-name investors.
Fraiser Kansteiner
Jun 2, 2026 8:00am
Organon hunts for new CEO after probe exposes sales misconduct
Oct 27, 2025 10:00am
FDA accuses Evofem of overstating efficacy of contraceptive gel
Nov 10, 2023 7:40am
Gilead-backed Lyndra lays off staff as it nears pivotal data
Sep 15, 2023 3:33pm
Bayer embraces imagery in new campaign for HMB
May 18, 2023 7:40am
Organon joins global push to prevent unintended pregnancies
Nov 29, 2022 10:25am
